Ecallantide

  • Biologic
  • Kalbitor

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Ecallantide: storage and handling

Refrigerate
Yes, as the label states
Label statement
KALBITOR should be kept refrigerated (2°C to 8°C/36°F to 46°F).
Freezing
Not addressed
Room temperature
up to 14 days at or below 30°C (86°F)
Label statement
Vials removed from refrigeration should be stored below 86°F/30°C and used within 14 days or returned to refrigeration until use.
Back into the refrigerator
Not addressed
Light
Not addressed
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (up to 14 days at up to 30°C (86°F)). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

Vials removed from refrigeration should be stored below 86°F/30°C and used within 14 days or returned to refrigeration until use.

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1-877-TAKEDA-7 (1-877-825-3327) (the number printed on the label) about this product.

Where the label prints this number
For more information, visit www.kalbitor.com or call 1-877-TAKEDA-7 (1-877-825-3327).
All storage statements on the label (3)
  • KALBITOR should be kept refrigerated (2°C to 8°C/36°F to 46°F).
  • Vials removed from refrigeration should be stored below 86°F/30°C and used within 14 days or returned to refrigeration until use.
  • Do not use beyond the expiration date.

FDA label version 19, effective July 1, 2025. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

No Part D formulary in the CMS files (2026Q3) lists this drug. It may be covered under Part B or not covered.

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.